Drug
Pazopanib
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Metastases To Lung | 100 | 41.5 | 42.4 | signal |
| 2 | Thyroid Cancer | 85 | 33.5 | 34.2 | signal |
| 3 | Malignant Neoplasm Progression | 513 | 24.0 | 27.0 | signal |
| 4 | Hair Colour Changes | 59 | 22.4 | 22.7 | signal |
| 5 | Pneumothorax | 63 | 18.9 | 19.2 | signal |
| 6 | Posterior Reversible Encephalopathy Syndrome | 36 | 18.0 | 18.2 | signal |
| 7 | Hepatotoxicity | 75 | 16.1 | 16.4 | signal |
| 8 | Metastases To Liver | 57 | 15.5 | 15.7 | signal |
| 9 | Palmar-plantar Erythrodysaesthesia Syndrome | 75 | 15.3 | 15.5 | signal |
| 10 | Proteinuria | 56 | 14.1 | 14.3 | signal |
| 11 | Metastases To Central Nervous System | 37 | 13.7 | 13.9 | signal |
| 12 | Metastases To Bone | 47 | 13.7 | 13.8 | signal |
| 13 | Blood Bilirubin Increased | 70 | 12.3 | 12.5 | signal |
| 14 | Neoplasm Progression | 82 | 11.1 | 11.3 | signal |
| 15 | Alanine Aminotransferase Increased | 136 | 10.5 | 10.8 | signal |
| 16 | Hepatic Function Abnormal | 82 | 10.5 | 10.7 | signal |
| 17 | Ascites | 65 | 10.5 | 10.7 | signal |
| 18 | Disease Progression | 257 | 10.4 | 10.9 | signal |
| 19 | Hypothyroidism | 68 | 10.2 | 10.3 | signal |
| 20 | Transaminases Increased | 46 | 9.8 | 9.9 | signal |
| 21 | Therapy Partial Responder | 31 | 9.8 | 9.8 | signal |
| 22 | Haematotoxicity | 19 | 9.7 | 9.8 | signal |
| 23 | Hyperbilirubinaemia | 21 | 9.7 | 9.7 | signal |
| 24 | Mucosal Inflammation | 52 | 9.5 | 9.6 | signal |
| 25 | Hypertensive Crisis | 21 | 8.9 | 9.0 | signal |
| 26 | Blood Thyroid Stimulating Hormone Increased | 17 | 8.8 | 8.8 | signal |
| 27 | Aspartate Aminotransferase Increased | 86 | 7.7 | 7.8 | signal |
| 28 | Ejection Fraction Decreased | 25 | 7.6 | 7.7 | signal |
| 29 | Intestinal Perforation | 18 | 7.6 | 7.6 | signal |
| 30 | Blood Alkaline Phosphatase Increased | 39 | 7.5 | 7.5 | signal |
| 31 | Gamma-glutamyltransferase Increased | 34 | 7.3 | 7.3 | signal |
| 32 | Jaundice | 40 | 7.0 | 7.1 | signal |
| 33 | Ileus | 18 | 7.0 | 7.0 | signal |
| 34 | Cardiomyopathy | 21 | 6.7 | 6.8 | signal |
| 35 | Pulmonary Mass | 21 | 6.7 | 6.7 | signal |
| 36 | Product Use In Unapproved Indication | 343 | 6.7 | 7.1 | signal |
| 37 | Hyperthyroidism | 20 | 6.6 | 6.6 | signal |
| 38 | Hypercalcaemia | 17 | 6.5 | 6.6 | signal |
| 39 | Pleural Effusion | 78 | 6.1 | 6.2 | signal |
| 40 | Drug-induced Liver Injury | 39 | 6.0 | 6.1 | signal |
| 41 | Thrombocytopenia | 139 | 5.9 | 6.1 | signal |
| 42 | Osteonecrosis Of Jaw | 30 | 5.7 | 5.8 | signal |
| 43 | Pneumonitis | 32 | 5.6 | 5.7 | signal |
| 44 | Flank Pain | 11 | 5.6 | 5.6 | signal |
| 45 | Febrile Neutropenia | 72 | 5.2 | 5.2 | signal |
| 46 | Liver Function Test Increased | 23 | 5.1 | 5.1 | signal |
| 47 | Liver Function Test Abnormal | 31 | 5.0 | 5.1 | signal |
| 48 | Pericardial Effusion | 24 | 5.0 | 5.0 | signal |
| 49 | Rebound Effect | 11 | 4.6 | 4.6 | signal |
| 50 | Haemoptysis | 26 | 4.4 | 4.4 | signal |
| 51 | Hepatic Failure | 28 | 4.4 | 4.4 | signal |
| 52 | Disseminated Intravascular Coagulation | 13 | 4.4 | 4.4 | signal |
| 53 | Malignant Melanoma | 12 | 4.2 | 4.3 | signal |
| 54 | Myocarditis | 10 | 4.2 | 4.2 | signal |
| 55 | Hyperglycaemia | 32 | 4.2 | 4.2 | signal |
| 56 | Blood Lactate Dehydrogenase Increased | 14 | 4.2 | 4.2 | signal |
| 57 | Hypertension | 185 | 4.1 | 4.3 | signal |
| 58 | Retinal Detachment | 8 | 4.1 | 4.1 | signal |
| 59 | Haematuria | 29 | 4.0 | 4.0 | signal |
| 60 | Cholecystitis | 10 | 4.0 | 4.0 | signal |
| 61 | Neutropenia | 113 | 4.0 | 4.0 | signal |
| 62 | Bone Marrow Failure | 17 | 3.9 | 4.0 | signal |
| 63 | Thrombotic Microangiopathy | 8 | 3.9 | 3.9 | signal |
| 64 | Cardiomegaly | 10 | 3.8 | 3.8 | signal |
| 65 | Haemorrhage Intracranial | 12 | 3.8 | 3.8 | signal |
| 66 | Blood Creatinine Increased | 52 | 3.8 | 3.8 | signal |
| 67 | Pulmonary Embolism | 74 | 3.7 | 3.7 | signal |
| 68 | Hepatocellular Injury | 11 | 3.7 | 3.7 | signal |
| 69 | General Physical Health Deterioration | 88 | 3.6 | 3.7 | signal |
| 70 | Brain Neoplasm | 7 | 3.6 | 3.6 | signal |
| 71 | Multiple Organ Dysfunction Syndrome | 21 | 3.6 | 3.6 | signal |
| 72 | Dehydration | 99 | 3.5 | 3.6 | signal |
| 73 | Hypocalcaemia | 14 | 3.5 | 3.5 | signal |
| 74 | Anaemia | 141 | 3.5 | 3.6 | signal |
| 75 | Acute Respiratory Distress Syndrome | 13 | 3.5 | 3.5 | signal |
| 76 | Decreased Appetite | 169 | 3.5 | 3.6 | signal |
| 77 | Renal Impairment | 61 | 3.5 | 3.5 | signal |
| 78 | Platelet Count Decreased | 75 | 3.3 | 3.4 | signal |
| 79 | Liver Injury | 17 | 3.3 | 3.3 | signal |
| 80 | Electrolyte Imbalance | 8 | 3.3 | 3.3 | signal |
| 81 | Hyponatraemia | 39 | 3.3 | 3.3 | signal |
| 82 | Hepatic Enzyme Increased | 47 | 3.3 | 3.3 | signal |
| 83 | Cardiac Failure | 55 | 3.3 | 3.3 | signal |
| 84 | Drug Level Decreased | 7 | 3.2 | 3.3 | signal |
| 85 | Multi-organ Failure | 12 | 3.2 | 3.3 | signal |
| 86 | Bacteraemia | 8 | 3.2 | 3.2 | signal |
| 87 | Rhabdomyolysis | 28 | 3.2 | 3.2 | signal |
| 88 | Sudden Death | 7 | 3.1 | 3.1 | signal |
| 89 | Mental Status Changes | 18 | 3.1 | 3.1 | signal |
| 90 | Myelosuppression | 22 | 3.1 | 3.1 | signal |
| 91 | Musculoskeletal Chest Pain | 10 | 3.1 | 3.1 | signal |
| 92 | Erythema Multiforme | 6 | 3.1 | 3.1 | signal |
| 93 | Colitis | 24 | 3.0 | 3.0 | signal |
| 94 | Lung Infection | 10 | 3.0 | 3.0 | signal |
| 95 | Hepatitis | 16 | 3.0 | 3.0 | signal |
| 96 | Drug Resistance | 16 | 3.0 | 3.0 | signal |
| 97 | Chromaturia | 14 | 2.9 | 2.9 | signal |
| 98 | Skin Ulcer | 16 | 2.9 | 2.9 | signal |
| 99 | Respiratory Failure | 45 | 2.9 | 2.9 | signal |
| 100 | Drug Interaction | 97 | 2.9 | 2.9 | signal |
| 101 | Neoplasm | 7 | 2.9 | 2.9 | signal |
| 102 | Hemiparesis | 10 | 2.8 | 2.8 | signal |
| 103 | Adrenal Insufficiency | 7 | 2.8 | 2.8 | signal |
| 104 | Stomatitis | 35 | 2.7 | 2.8 | signal |
| 105 | Cholestasis | 11 | 2.7 | 2.7 | signal |
| 106 | Hyperkalaemia | 20 | 2.7 | 2.7 | signal |
| 107 | Small Intestinal Obstruction | 7 | 2.7 | 2.7 | signal |
| 108 | Brain Oedema | 7 | 2.6 | 2.6 | signal |
| 109 | Cardiovascular Disorder | 14 | 2.6 | 2.6 | signal |
| 110 | Melaena | 12 | 2.6 | 2.6 | signal |
| 111 | Pancreatitis Acute | 12 | 2.6 | 2.6 | signal |
| 112 | Aphasia | 16 | 2.5 | 2.5 | signal |
| 113 | Nervous System Disorder | 16 | 2.4 | 2.4 | signal |
| 114 | Pancreatitis | 27 | 2.4 | 2.4 | signal |
| 115 | Body Temperature Decreased | 5 | 2.4 | 2.4 | no signal |
| 116 | Lymphopenia | 7 | 2.4 | 2.4 | signal |
| 117 | Inappropriate Antidiuretic Hormone Secretion | 5 | 2.3 | 2.3 | no signal |
| 118 | Cerebral Infarction | 12 | 2.3 | 2.3 | signal |
| 119 | Subarachnoid Haemorrhage | 5 | 2.3 | 2.3 | no signal |
| 120 | Lymphadenopathy | 17 | 2.3 | 2.3 | signal |
| 121 | Pancytopenia | 26 | 2.2 | 2.2 | signal |
| 122 | Therapeutic Response Decreased | 28 | 2.2 | 2.2 | signal |
| 123 | Nodule | 6 | 2.2 | 2.2 | no signal |
| 124 | Transient Ischaemic Attack | 15 | 2.1 | 2.1 | signal |
| 125 | Disease Recurrence | 21 | 2.1 | 2.1 | signal |
| 126 | Central Nervous System Lesion | 6 | 2.1 | 2.1 | no signal |
| 127 | Ovarian Cancer | 4 | 2.1 | 2.1 | no signal |
| 128 | Gastrointestinal Haemorrhage | 36 | 2.0 | 2.0 | signal |
| 129 | Polyneuropathy | 5 | 2.0 | 2.0 | no signal |
| 130 | Cerebral Haemorrhage | 15 | 2.0 | 2.0 | no signal |
| 131 | Cytopenia | 5 | 2.0 | 2.0 | no signal |
| 132 | Renal Failure Acute | 18 | 2.0 | 2.0 | no signal |
| 133 | Electrocardiogram Qt Prolonged | 15 | 2.0 | 2.0 | no signal |
| 134 | Pneumocystis Jirovecii Pneumonia | 4 | 1.9 | 1.9 | no signal |
| 135 | Ischaemic Stroke | 7 | 1.9 | 1.9 | no signal |
| 136 | Thyroid Disorder | 6 | 1.8 | 1.8 | no signal |
| 137 | Dysgeusia | 29 | 1.8 | 1.8 | no signal |
| 138 | Acute Myeloid Leukaemia | 6 | 1.8 | 1.8 | no signal |
| 139 | Eye Haemorrhage | 5 | 1.8 | 1.8 | no signal |
| 140 | Neutrophil Count Decreased | 15 | 1.8 | 1.8 | no signal |
| 141 | Acute Hepatic Failure | 5 | 1.7 | 1.7 | no signal |
| 142 | Cytokine Release Syndrome | 7 | 1.7 | 1.7 | no signal |
| 143 | Renal Injury | 11 | 1.7 | 1.7 | no signal |
| 144 | Nephropathy Toxic | 4 | 1.7 | 1.7 | no signal |
| 145 | Fistula | 4 | 1.7 | 1.7 | no signal |
| 146 | Death | 304 | 1.7 | 1.7 | no signal |
| 147 | Drug Effect Incomplete | 13 | 1.7 | 1.7 | no signal |
| 148 | Interstitial Lung Disease | 17 | 1.7 | 1.7 | no signal |
| 149 | Myelodysplastic Syndrome | 5 | 1.6 | 1.6 | no signal |
| 150 | Neurotoxicity | 6 | 1.6 | 1.6 | no signal |
| 151 | Peritonitis | 7 | 1.6 | 1.6 | no signal |
| 152 | No Therapeutic Response | 4 | 1.5 | 1.5 | no signal |
| 153 | Grand Mal Convulsion | 3 | 1.5 | 1.5 | no signal |
| 154 | Toxicity To Various Agents | 52 | 1.5 | 1.5 | no signal |
| 155 | Injection Site Induration | 4 | 1.5 | 1.5 | no signal |
| 156 | Renal Cancer | 13 | 1.3 | 1.3 | no signal |
| 157 | Hepatic Cytolysis | 3 | 1.2 | 1.2 | no signal |
| 158 | Anorexia | 3 | 1.1 | 1.1 | no signal |
| 159 | Drug Effective For Unapproved Indication | 6 | 1.0 | 1.0 | no signal |
| 160 | Gastric Cancer | 4 | 0.7 | 0.7 | no signal |
| 161 | Needle Issue | 4 | 0.7 | 0.7 | no signal |